United Kingdom· GB-APID-44434411000001107
Lunivia 3mg tablets
A eszopiclone product containing eszopiclone, registered in United Kingdom by Axunio Pharma GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eszopiclone is registered in 10 of 19 countries.
Countries holding a registration under ATC N05CF04 (eszopiclone), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Eszopiclone · ATC N05CF04
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Japan
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of eszopiclone costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eszopiclone · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- FR France$0.13
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eszopiclone
- Manufacturer
- Axunio Pharma GmbH
- Country
- United Kingdom (GB)
- ATC code
- N05CF04
- ATC class
- Eszopiclone
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin04260602270607
- gtin4260602270607
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
126 interactions on record for eszopiclone.
Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eszopiclone · interactions on record
126 records
- 13 severe
- 113 moderate
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- Darunavir and cobicistatJ05AR14severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eszopiclone in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaLUNESTASUMITOMO PHARMA CANADA, INC.
- United StatesEszopicloneTeva Pharmaceuticals USA, Inc.
- CzechiaESOGNOG.L. Pharma GmbH, Lannach
- FinlandLuniviaAlfred E. Tiefenbacher (GmbH & Co. KG)
- BelgiumEsnoxiben 1 mgAlfred E. Tiefenbacher
- FranceNOXIBEN 1 mg, comprimé pelliculéG.L. PHARMA (AUTRICHE)
- PolandEsognoG.L. Pharma GmbH
- GermanyEsognoG.L. Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Esogno
- Bulgaria · Есогно
- Czechia · Esogno
- Germany · Esogno, Lunivia
- Estonia · Esogno
- France · Noxiben
- Hungary · Esogno
- Italy · Esnoxiben
- Lithuania · Esogno
- Latvia · Esogno
- Poland · Esogno
- Slovakia · Esogno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15bf4d7a-f4b1-4b49-aa50-396dc57bbc54 GET /v1/drugs/15bf4d7a-f4b1-4b49-aa50-396dc57bbc54?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44434411000001107",
"desc": "Lunivia 3mg tablets (Axunio Pharma GmbH)",
"form": "Oral tablet",
"vpid": "44546611000001107",
"source": "dmd",
"vtm_id": "775847006",
"strength": "3 mg",
"substance": "Eszopiclone",
"ingredient": "Eszopiclone",
"supplier_code": "39910311000001103"
}See everything about eszopiclone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.